Zhejiang Wecome Pharmaceutical's high P/S ratio is alarming ...

Zhejiang Wecome Pharmaceutical's high P/S ratio is alarming considering its recent revenue drop. This trend could jeopardize shareholders' investments and deter potential investors. The share price might decrease, making the P/S more reasonable.